Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1423053 MIAMI, FL
Back to MDGL Full portfolio

Position in MDGL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$237,573,195
+$216,530,923 QoQ
Shares Held
453,843
+1156.0% QoQ
Ownership
1.97%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in MDGL Over Time

Shares Held

Position Value (USD)

Derivatives in MDGL

reported options exposure · as of Mar 31, 2026
CallValue
$58,838,028
CallShares
112,400
PutValue
$19,001,961
PutShares
36,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,783,571,443 across 373 Biotechnology names. MDGL ranks #5 (4.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 2,182,571 $356,894,009
2 ONC
BeOne Medicines Ltd.
 1,032,298 $306,561,536
3 BMRN
Biomarin Pharmaceutical Inc
 4,512,634 $254,918,694
4 JAZZ
Jazz Pharmaceuticals plc
 1,259,444 $238,097,887
5 MDGL
Madrigal Pharmaceuticals, Inc.
This page 		453,843 $237,573,195
6 BBIO
BridgeBio Pharma, Inc.
 3,173,940 $235,696,783
7 TERN
Terns Pharmaceuticals, Inc.
 3,218,810 $169,695,662
8 PTGX
Protagonist Therapeutics, Inc
 1,551,900 $163,570,260

All Filings in MDGL

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $58,838,028 112,400
2026-03-31 $237,573,195 453,843
2026-03-31 $19,001,961 36,300
2025-12-31 $61,087,466 104,900
2025-12-31 $21,042,272 36,134
2025-12-31 $25,098,854 43,100
2025-09-30 $22,186,300 48,372
2025-09-30 $29,262,508 63,800
2025-09-30 $27,427,868 59,800
2025-06-30 $14,466,192 47,800
2025-06-30 $62,749,074 207,339
2025-06-30 $16,766,256 55,400
2025-03-31 $265,315 801
2025-03-31 $12,288,633 37,100
2025-03-31 $22,689,255 68,500
2024-12-31 $23,266,178 75,400
2024-12-31 $4,589,052 14,872
2024-12-31 $26,351,878 85,400
2024-09-30 $16,553,160 78,000
2024-09-30 $11,597,610 54,649
2024-09-30 $11,374,992 53,600
2024-06-30 $20,255,568 72,300
2024-06-30 $3,134,990 11,190
2024-06-30 $15,969,120 57,000
2024-03-31 $21,897,280 82,000
2024-03-31 $6,572,388 24,612
2024-03-31 $29,561,328 110,700
2023-12-31 $2,427,638 10,492
2023-12-31 $11,730,966 50,700
2023-12-31 $15,016,562 64,900
2023-09-30 $5,739,372 39,300
2023-09-30 $40,427,668 276,826
2023-09-30 $9,171,312 62,800
2023-06-30 $19,382,979 83,909
2023-06-30 $27,234,900 117,900
2023-06-30 $11,896,500 51,500
2023-03-31 $19,017,410 78,500
2023-03-31 $15,795,352 65,200
2023-03-31 $32,497,724 134,144
2022-12-31 $73,172,025 252,100
2022-12-31 $49,425,801 170,287
2022-12-31 $49,110,300 169,200
2022-09-30 $2,738,938 42,144
2022-09-30 $2,099,177 32,300
2022-09-30 $6,115,559 94,100
2022-06-30 $4,029,954 56,300
2022-06-30 $3,764,177 52,587
2022-06-30 $2,519,616 35,200
2022-03-31 $5,833,429 59,452
2022-03-31 $1,991,836 20,300

Report a Problem

Category
Description
Email (optional, for follow-up)